Business|Health
J&J beats Wall St estimates on strong drug sales ahead of Stelara competition
(This July 17 story has been corrected to clarify that the CFO did not suggest that pending Stelara insurance contracts would be 'favorable,' in paragraph 4) By Patrick Wingrove and Bhanvi Satija (
July 17, 2024